(Q33602968)

28 July 2017

Irreversible corneal decompensation in patients treated with topical dorzolamide (English)

1 reference

28 July 2017

Konowal A

1

1 reference

28 July 2017

Morrison JC

2

1 reference

28 July 2017

Brown SV

3

1 reference

28 July 2017

Cooke DL

4

1 reference

28 July 2017

Maguire LJ

5

1 reference

28 July 2017

Verdier DV

6

1 reference

28 July 2017

Fraunfelder FT

7

1 reference

28 July 2017

Dennis RF

8

1 reference

28 July 2017

Epstein RJ

9

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 April 1999

1 reference

American Journal of Ophthalmology

28 July 2017

1 reference

28 July 2017

127

1 reference

28 July 2017

4

1 reference

28 July 2017

403-406

1 reference

Dorzolamide: development and clinical application of a topical carbonic anhydrase inhibitor

28 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2898%2900438-3

MK-507 (L-671,152), a topically active carbonic anhydrase inhibitor, reduces aqueous humor production in monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2898%2900438-3

MK-507 versus sezolamide. Comparative efficacy of two topically active carbonic anhydrase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2898%2900438-3

Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2898%2900438-3

Dose response and duration of action of dorzolamide, a topical carbonic anhydrase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2898%2900438-3

Corneal endothelium five years after transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2898%2900438-3

Long-term morphologic changes in the endothelium of transplanted corneas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2898%2900438-3

The effect of allograft rejection after penetrating keratoplasty on central endothelial cell density

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2898%2900438-3

Endothelial cell loss after phacoemulsification and insertion of silicone lens implants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2898%2900438-3

Combination of systemic acetazolamide and topical dorzolamide in reducing intraocular pressure and aqueous humor formation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2898%2900438-3

A double-masked, randomized, 1-year study comparing the corneal effects of dorzolamide, timolol, and betaxolol. Dorzolamide Corneal Effects Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2898%2900438-3

10.1016/S0002-9394(98)00438-3

7 January 2021

Identifiers

DOI

1 reference

28 July 2017

1 reference